14-8822-37
antibody from Invitrogen Antibodies
Targeting: GZMB
CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT
Antibody data
- Antibody Data
- Antigen structure
- References [20]
- Comments [0]
- Validations
- Other assay [5]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14-8822-37 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Granzyme B Monoclonal Antibody (16G6), eBioscience™
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Description: The 16G6 antibody reacts with mouse Granzyme B (GrB) which is a member of the granzyme serine protease family. GrB is found in the granules of cytotoxic T cells and NK cells. Granzyme B has also been described as CGL1 (cathepsin G-like-1), a serine protease expressed only in cytotoxic T-lymphocytes after cell activation. GrB has been called CTLA-1 (cytotoxic T lymphocyte-associated serine esterase 1) based on identification of mRNA in various cytotoxic T cells, but not observed in non-cytotoxic lymphoid cells. GrB is crucial for the rapid induction of target cell death by apoptosis, induced by interaction with cytotoxic T cells. The receptor involved has been identified as mannose 6-phosphate receptor. This receptor functions as a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. For intracellular staining and flow cytometric analysis with direct conjugates of anti-mouse Granzyme B, it is highly recommended to use the Foxp3 Staining Buffer Set (Product # 00-5523). Other buffers may yield varying results. Applications Reported: This 16G6 antibody has been reported for use in western blotting, immunohistochemical staining, ELISA capture antibody, and immunohistochemical staining of formalin-fixed paraffin embedded tissue sections. Applications Tested: The unlabelled 16G6 antibody has been tested as the capture antibody in a sandwich ELISA for quantitation of mouse granzyme B protein levels, in combination with the biotinylated eBioLUEE (Product # 13-8821-81) antibody for detection and recombinant mouse granzyme B as the standard. A suitable range of concentrations of this antibody for ELISA detection is 1-4 µg/mL. The 16G6 antibody has been tested for Western blotting; a recommended starting concentration is 1 µg/mL. The 16G6 antibody has been used for formalin-fixed paraffin embedded tissue using low pH antigen retrieval at less than or equal to 20 µg/mL. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. Purity: Greater than 90%, as determined by SDS-PAGE. Aggregation: Less than 10%, as determined by HPLC. Filtration: 0.2 µm post-manufacturing filtered.
- Reactivity
- Human, Mouse
- Host
- Rat
- Isotype
- IgG
- Antibody clone number
- 16G6
- Vial size
- 2 mg
- Concentration
- 0.5 mg/mL
- Storage
- 4° C
Submitted references Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.
Regulation of the effector function of CD8(+) T cells by gut microbiota-derived metabolite butyrate.
PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Imaging Granzyme B Activity Assesses Immune-Mediated Myocarditis.
The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress.
A natural genetic variant of granzyme B confers lethality to a common viral infection.
IL-2 induction of Blimp-1 is a key in vivo signal for CD8+ short-lived effector T cell differentiation.
Coreceptor gene imprinting governs thymocyte lineage fate.
Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells.
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.
A LysM and SH3-domain containing region of the Listeria monocytogenes p60 protein stimulates accessory cells to promote activation of host NK cells.
Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice.
Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection.
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.
IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo.
De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system.
IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.
Enhancement of CD8 T-cell function through modifying surface glycoproteins in young and old mice.
Jiang L, Wang YJ, Zhao J, Uehara M, Hou Q, Kasinath V, Ichimura T, Banouni N, Dai L, Li X, Greiner DL, Shultz LD, Zhang X, Sun ZJ, Curtin I, Vangos NE, Yeoh ZC, Geffken EA, Seo HS, Liu ZX, Heffron GJ, Shah K, Dhe-Paganon S, Abdi R
Cell 2020 Nov 25;183(5):1219-1233.e18
Cell 2020 Nov 25;183(5):1219-1233.e18
Regulation of the effector function of CD8(+) T cells by gut microbiota-derived metabolite butyrate.
Luu M, Weigand K, Wedi F, Breidenbend C, Leister H, Pautz S, Adhikary T, Visekruna A
Scientific reports 2018 Sep 26;8(1):14430
Scientific reports 2018 Sep 26;8(1):14430
PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Wang J, Xie T, Wang B, William WN Jr, Heymach JV, El-Naggar AK, Myers JN, Caulin C
Cancer prevention research (Philadelphia, Pa.) 2017 Dec;10(12):684-693
Cancer prevention research (Philadelphia, Pa.) 2017 Dec;10(12):684-693
Imaging Granzyme B Activity Assesses Immune-Mediated Myocarditis.
Konishi M, Erdem SS, Weissleder R, Lichtman AH, McCarthy JR, Libby P
Circulation research 2015 Aug 28;117(6):502-512
Circulation research 2015 Aug 28;117(6):502-512
The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress.
Bird CH, Christensen ME, Mangan MS, Prakash MD, Sedelies KA, Smyth MJ, Harper I, Waterhouse NJ, Bird PI
Cell death and differentiation 2014 Jun;21(6):876-87
Cell death and differentiation 2014 Jun;21(6):876-87
A natural genetic variant of granzyme B confers lethality to a common viral infection.
Andoniou CE, Sutton VR, Wikstrom ME, Fleming P, Thia KY, Matthews AY, Kaiserman D, Schuster IS, Coudert JD, Eldi P, Chaudhri G, Karupiah G, Bird PI, Trapani JA, Degli-Esposti MA
PLoS pathogens 2014 Dec;10(12):e1004526
PLoS pathogens 2014 Dec;10(12):e1004526
IL-2 induction of Blimp-1 is a key in vivo signal for CD8+ short-lived effector T cell differentiation.
Boulet S, Daudelin JF, Labrecque N
Journal of immunology (Baltimore, Md. : 1950) 2014 Aug 15;193(4):1847-54
Journal of immunology (Baltimore, Md. : 1950) 2014 Aug 15;193(4):1847-54
Coreceptor gene imprinting governs thymocyte lineage fate.
Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A
The EMBO journal 2012 Jan 18;31(2):366-77
The EMBO journal 2012 Jan 18;31(2):366-77
Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
Wiesel M, Crouse J, Bedenikovic G, Sutherland A, Joller N, Oxenius A
European journal of immunology 2012 Feb;42(2):320-9
European journal of immunology 2012 Feb;42(2):320-9
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells.
Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M
The Journal of clinical investigation 2012 Feb;122(2):575-85
The Journal of clinical investigation 2012 Feb;122(2):575-85
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.
Zappasodi R, Bongarzone I, Ghedini GC, Castagnoli L, Cabras AD, Messina A, Tortoreto M, Tripodo C, Magni M, Carlo-Stella C, Gianni AM, Pupa SM, Di Nicola M
Blood 2011 Oct 20;118(16):4421-30
Blood 2011 Oct 20;118(16):4421-30
A LysM and SH3-domain containing region of the Listeria monocytogenes p60 protein stimulates accessory cells to promote activation of host NK cells.
Schmidt RL, Filak HC, Lemon JD, Potter TA, Lenz LL
PLoS pathogens 2011 Nov;7(11):e1002368
PLoS pathogens 2011 Nov;7(11):e1002368
Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice.
Tabbekh M, Franciszkiewicz K, Haouas H, Lécluse Y, Benihoud K, Raman C, Mami-Chouaib F
Journal of immunology (Baltimore, Md. : 1950) 2011 Jul 1;187(1):102-9
Journal of immunology (Baltimore, Md. : 1950) 2011 Jul 1;187(1):102-9
Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection.
McCarl CA, Khalil S, Ma J, Oh-hora M, Yamashita M, Roether J, Kawasaki T, Jairaman A, Sasaki Y, Prakriya M, Feske S
Journal of immunology (Baltimore, Md. : 1950) 2010 Nov 15;185(10):5845-58
Journal of immunology (Baltimore, Md. : 1950) 2010 Nov 15;185(10):5845-58
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.
Xie Y, Akpinarli A, Maris C, Hipkiss EL, Lane M, Kwon EK, Muranski P, Restifo NP, Antony PA
The Journal of experimental medicine 2010 Mar 15;207(3):651-67
The Journal of experimental medicine 2010 Mar 15;207(3):651-67
IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo.
Haeberlein S, Sebald H, Bogdan C, Schleicher U
European journal of immunology 2010 Jun;40(6):1708-17
European journal of immunology 2010 Jun;40(6):1708-17
De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system.
Zhao J, Zhao J, Perlman S
Journal of immunology (Baltimore, Md. : 1950) 2009 Oct 15;183(8):5163-70
Journal of immunology (Baltimore, Md. : 1950) 2009 Oct 15;183(8):5163-70
IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
Itsumi M, Yoshikai Y, Yamada H
European journal of immunology 2009 Jul;39(7):1784-93
European journal of immunology 2009 Jul;39(7):1784-93
Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.
Ahonen CL, Wasiuk A, Fuse S, Turk MJ, Ernstoff MS, Suriawinata AA, Gorham JD, Kedl RM, Usherwood EJ, Noelle RJ
Blood 2008 Mar 15;111(6):3116-25
Blood 2008 Mar 15;111(6):3116-25
Enhancement of CD8 T-cell function through modifying surface glycoproteins in young and old mice.
Sadighi Akha AA, Berger SB, Miller RA
Immunology 2006 Oct;119(2):187-94
Immunology 2006 Oct;119(2):187-94
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL